Giovanni Damiani to Infliximab
This is a "connection" page, showing publications Giovanni Damiani has written about Infliximab.
Connection Strength
0.041
-
Switching infliximab in psoriatic patients during COVID-19 pandemics: A real-life retrospective study comparing intra-versus interclass switching strategies. Dermatol Ther. 2021 Sep; 34(5):e15088.
Score: 0.041